In the latest trading session, Boston Scientific (BSX) closed at $102.27, marking a +0.32% move from the previous day. The stock's performance was ahead of the S&P 500's daily loss of 1.46%. On the ...

Physicians also expect greater use of Johnson & Johnson’s Varipulse system over the next two years despite the company’s ...

Deutsche Bank has recently raised Boston Scientific Corp (BSX) stock to Buy rating, as announced on January 10, 2025, according to Finviz. Earlier, on October 18, 2024, Needham had reduced the stock ...

We recently compiled a list of the 12 Best Fundamental Stocks to Buy Now. In this article, we are going to take a look at ...

In a report released yesterday, Shagun Singh Chadha from RBC Capital reiterated a Buy rating on Boston Scientific (BSX – Research Report), with ...

Blame large-scale weather patterns for this storm track, which National Weather Service meteorologist Zack Taylor calls "not ...

The U.S. Food and Drug Administration (FDA) has announced that Boston Scientific Corporation is updating use instructions for POLARx and POLARx FIT Cryoablation Balloon Catheters, emphasizing the risk ...

Boston Scientific’s BSX robust expansion of operations across different geographies outside the United States is poised to help it grow in the upcoming quarters. The company’s ...

Boston Scientific closes the year at historic highs, with investors refusing to liquidate even at these levels. The smooth upward movement of the stock indicates the quality of its investor base.

The exciting scientific developments present threats as well as opportunities. Dozens of leading researchers including two Nobel Prize winners have warned of the potentially catastrophic impact of ...